Abstract:Background: Gastric cancer (GC), one of the most common causes of malignant tumors, is characterized by a high degree of heterogeneity, which represents a bottleneck in gaining comprehensive insights into its pathogenesis. Negative regulator of ubiquitin-like proteins 1 (NUB1) is a transcription factor that negatively regulates ubiquitylation system. Although the abnormal expression of NUB1 has been reported in many types of cancer, its expression pattern and functions in GC are poorly understood. Materials and methods: The link between NUB1 expression and clinicopathological characteristics was analyzed by immunohistochemical staining, and the suitability of NUB1 as a prognostic marker was explored using a public database on mRNA expression levels. NUB1 overexpression was performed by lentiviral transfection. Cell proliferation was estimated using the cell counting kit-8 (CCK-8) assay. The effect on NUB1 on cell cycle was analyzed by fluorescence-activated cell sorting (FACS). Real-time PCR (RT-PCR) and western blotting experiments were used to explore the mechanism of p27Kip1 regulation by NUB1. Cell migration and invasion were determined by wound healing and transwell assays, respectively. Expression levels of epithelial-mesenchymal transition (EMT) indicator proteins were determined by western blotting. Results: In this study, based on a comparative analysis of cancer tissues from 116 post-operative GC patients with the respective paracancerous healthy tissues, we found that NUB1 was downregulated in GC tissues. At the same time, a low expression level of NUB1 was closely related to poor prognosis. Results from In vitro cancer cell experiments verified that overexpressed NUB1 inhibited GC proliferation, migration, and invasion. In addition, NUB1 upregulated the expression of p27Kip1 and blocked the G1/S phase transition in cell cycle. Finally, NUB1 inhibited the process of EMT by upregulating E-cadherin and downregulating N-cadherin, vimentin, and matrix metalloproteinase-2 (MMP-2). Conclusion: Reduced NUB1 levels were positively associated to poor prognosis of GC, whereas NUB1 over-expression inhibited the proliferation and blocked the G1/S phase transition in GC cells. This may be strongly coupled to the post-translational modification mechanism (PTM), which could, in turn, reduce the level of ubiquitinylated p27Kip1 and upregulate its expression. In addition, NUB1 overexpression inhibited GC migration and invasion by regulating EMT. In view of the positive tumor-suppressive effect of NUB1 on GC occurrence and progression reported here, this study enhances our understanding of the molecular mechanism of NUB1-mediated GC regulation, and may provide insights into novel drug targets or anti-tumor strategies with better accuracy and efficacy.

NUBPL, a Novel Metastasis-Related Gene, Promotes Colorectal Carcinoma Cell Motility by Inducing Epithelial-Mesenchymal Transition.

Numb Negatively Regulates the Epithelial-to-mesenchymal Transition in Colorectal Cancer Through the Wnt Signaling Pathway.

Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

NUDCD1 Promotes Metastasis Through Inducing EMT and Inhibiting Apoptosis in Colorectal Cancer.

High NUCB2 Expression Level is Associated with Metastasis and May Promote Tumor Progression in Colorectal Cancer

PLAGL2 Promotes Epithelial–mesenchymal Transition and Mediates Colorectal Cancer Metastasis Via Β-Catenin-dependent Regulation of ZEB1

Phosphorylation and Changes in the Distribution of Nucleolin Promote Tumor Metastasis Via the PI3K/Akt Pathway in Colorectal Carcinoma

NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway

Pleomorphic Adenoma Gene Like-2 Induces Epithelial-Mesenchymal Transition Via Wnt/β-catenin Signaling Pathway in Human Colorectal Adenocarcinoma.

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis

Decreased Expression of PLD2 Promotes EMT in Colorectal Cancer Invasion and Metastasis

Overexpression of Negative Regulator of Ubiquitin-Like Proteins 1 (NUB1) Inhibits Proliferation and Invasion of Gastric Cancer Cells Through Upregulation of P27kip1 and Inhibition of Epithelial-Mesenchymal Transition

SETBP1 Activation Upon MDM4-enhanced Ubiquitination of NR3C1 Triggers Dissemination of Colorectal Cancer Cells

Nuclear Factor I/B Promotes Colorectal Cancer Cell Proliferation, Epithelial-Mesenchymal Transition and 5-Fluorouracil Resistance

LncRNA LINC00342 contributes to the growth and metastasis of colorectal cancer via targeting miR-19a-3p/NPEPL1 axis

Ribosomal L22-Like1 (Rpl22l1) Promotes Ovarian Cancer Metastasis By Inducing Epithelial-To-Mesenchymal Transition

Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer

Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.

Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA‐152‐3p and regulating E2F3/MAPK8 signaling

LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition